P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 20 August 2018 | 6:55 pm

Novo Nordisk A/S - Share repurchase programme

Bagsværd, Denmark, 20 August 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the more ...

Published 20 August 2018 | 4:46 pm

Pfizer Invites Public To View And Listen To Webcast Of August 27 Conference Call With Analysts And Investors To Review Tafamidis Data Presentation At ESC Congress 2018

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Monday, August 27, 2018 at 9:00 a.m. EDT. more ...

Published 20 August 2018 | 3:10 pm

Abbott on Fortune Change the World List

Fortune honors Abbott for creating positive social impact through business, highlights shared value dairy initiative. more ...

Published 20 August 2018 | 2:28 pm

Oral semaglutide provides superior HbA1c and weight reductions versus placebo in people with type 2 diabetes and renal impairment in the PIONEER 5 trial

Bagsværd, Denmark, 20 August 2018 - Novo Nordisk today announced the headline results from PIONEER 5, a phase 3a trial with oral semaglutide in adults with type 2 more ...

Published 20 August 2018 | 2:22 pm

Making fragility fractures a public health priority

Posted by Anja-Lucia Hillestrom, Patient Value Unit - Bone 20-Aug-2018 more ...

Published 20 August 2018 | 8:13 am

AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018

New evidence of the persistency of ischaemic risk in post-heart attack patients, highlighting specific risk factors that may help identify patients for extended DAPT more ...

Published 20 August 2018 | 7:03 am

Media Release

China National Drug Administration grants rapid approval of Roche's Alecensa (alectinib) as a treatment for ALK-positive lung cancer Approval follows priority review of Alecensa more ...

Published 17 August 2018 | 2:23 pm

CSL beschleunigt Wachstum

CSL-Gruppe präsentiert Rekordergebnisse für das Geschäftsjahr 2017/2018. more ...

Published 17 August 2018 | 1:22 pm

Press Release

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung more ...

Published 17 August 2018 | 11:05 am

Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins

Novo Nordisk gains full rights to Ziylo's early-stage glucose binding molecules in a staged acquisition with a potential deal value that could exceed 800 million US dollars more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018